Evidence map›Paper›PMID 38560336›Full record

ArticleJournal of pharmacopuncture2024

Enhanced Drug Carriage Efficiency of Curcumin-Loaded PLGA Nanoparticles in Combating Diabetic Nephropathy via Mitigation of Renal Apoptosis.

Asmita Samadder, Banani Bhattacharjee, Sudatta Dey, Arnob Chakrovorty, Rishita Dey, Priyanka Sow, Debojyoti Tarafdar, Maharaj Biswas, Sisir Nandi

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmacopuncture, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Preclinical Evidence ofBiomedicines · 2025
    Review
  4. Green Synthesis of Chlorophyllin-Based Ag Nanoparticles to TargetRecent advances in drug delivery and formulation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Asmita SamadderCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0002-3604-7404
Banani BhattacharjeeCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0001-6290-3430
Sudatta DeyCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0003-4867-1674
Arnob ChakrovortyCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0003-4147-4651
Rishita DeyCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0002-6584-8083
Priyanka SowCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0002-0280-1077
Debojyoti TarafdarDepartment of Chemistry, Chanchal College, Affiliated to The University of Gour Banga, West Bengal, India.ORCID https://orcid.org/0000-0001-8358-9196
Maharaj BiswasEndocrinology and Reproductive Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India.ORCID https://orcid.org/0000-0001-5142-3730
Sisir NandiDepartment of Pharmaceutical Chemistry, Global Institute of Pharmaceutical Education and Research, Veer Madho Singh Bhandari Uttarakhand Technical University, Kashipur, India.ORCID https://orcid.org/0000-0002-9960-6584
University of Kalyani · INUttarakhand Technical University · INUniversity of Gour Banga · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The Methods: Upon Results: The Conclusion: This study essentially validates the potential of NCUR to inhibit DN by reducing blood glucose level and mitigating glomerular apoptosis by selectively promoting Bcl2 protein expression in kidney tissue.

Indexed as

Bcl2glomerulusin silico molecular dockingkidneynanomedicinePLGA encapsulated nano-curcumin

Identifiers

PMID38560336
PMCPMC10978441
OpenAlexW4393271644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.